Simon Bowler

机构：Mater Adult Hospital · ORCID：0000-0002-2387-2675

发表论文 103 篇 · 总被引 2992 次 · h-index 31

代表论文

• Effect of Long-term, Low-Dose Erythromycin on Pulmonary Exacerbations Among Patients With Non–Cystic Fibrosis Bronchiectasis (2013 · JAMA · 被引 421)
• Mepolizumab effectiveness and identification of super-responders in severe asthma (2020 · European Respiratory Journal · 被引 199)
• Airway Mucus Hyperconcentration in Non–Cystic Fibrosis Bronchiectasis (2019 · American Journal of Respiratory and Critical Care Medicine · 被引 140)
• Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients (2023 · Allergy · 被引 97)
• Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry (2016 · Internal Medicine Journal · 被引 84)
• Pamrevlumab for Idiopathic Pulmonary Fibrosis (2024 · JAMA · 被引 79)